Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EU decision-making for marketing authorization of advanced therapy medicinal products: a case study
Sofieke de Wilde, D. Coppens, Jarno Hoekman, et al.
Drug Discovery Today (2018) Vol. 23, Iss. 7, pp. 1328-1333
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Automation in cell and gene therapy manufacturing: from past to future
Panagiota Moutsatsou, Jelena Ochs, Robert Schmitt, et al.
Biotechnology Letters (2019) Vol. 41, Iss. 11, pp. 1245-1253
Open Access | Times Cited: 90
Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical products
Juan José Novoa, Inge M. Westra, Esther Steeneveld, et al.
Cytotherapy (2024) Vol. 26, Iss. 6, pp. 556-566
Open Access | Times Cited: 10
Current landscape of clinical development and approval of advanced therapies
Carolina Iglesias-López, Antònia Agustí, Antonio Vallano, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 606-618
Open Access | Times Cited: 38
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals
Magdi Elsallab, Christopher A. Bravery, Armin Kurtz, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 18, pp. 269-279
Open Access | Times Cited: 38
Regenerative medicine regulatory policies: A systematic review and international comparison
Tingting Qiu, Eve Hanna, Monique Dabbous, et al.
Health Policy (2020) Vol. 124, Iss. 7, pp. 701-713
Open Access | Times Cited: 34
Advanced therapy medicinal products in China: Regulation and development
Jiaqi Lü, Longchang Xu, Wei Wei, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 12
Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study
Sharon Essink, Inge M. Zomerdijk, Sabine M. J. M. Straus, et al.
Drug Safety (2025)
Open Access
The Human Genome Editing Race: Loosening Regulatory Standards for Commercial Advantage?
Toni Cathomen, Silke Schüle, Martina Schüßler‐Lenz, et al.
Trends in biotechnology (2018) Vol. 37, Iss. 2, pp. 120-123
Closed Access | Times Cited: 24
Advanced Therapies and Regulatory Framework in Different Areas of the Globe: Past, Present, and Future
Cleila Pimenta, Vitória Bettiol, Thuany Alencar‐Silva, et al.
Clinical Therapeutics (2021) Vol. 43, Iss. 5, pp. e103-e138
Closed Access | Times Cited: 19
Hurdles in gene therapy regulatory approval: a retrospective analysis of European Marketing Authorization Applications
Marta Carvalho, Ana Paula Martins, Bruno Sepodes
Drug Discovery Today (2018) Vol. 24, Iss. 3, pp. 823-828
Open Access | Times Cited: 23
Validating human induced pluripotent stem cell-specific quality control tests for the release of an intermediate drug product in a Good Manufacturing Practice quality system
Juan José Novoa, Inge M. Westra, Esther Steeneveld, et al.
Cytotherapy (2024) Vol. 26, Iss. 9, pp. 1105-1117
Open Access | Times Cited: 2
A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature
Renske M.T. ten Ham, Olaf H. Klungel, Hubert G. M. Leufkens, et al.
Value in Health (2020) Vol. 23, Iss. 9, pp. 1268-1280
Open Access | Times Cited: 18
Translating Cell and Gene Biopharmaceutical Products for Health and Market Impact. Product Scaling From Clinical to Marketplace: Lessons Learned and Future Outlook
Annette Bak, Kristina Pagh Friis, Yan Wu, et al.
Journal of Pharmaceutical Sciences (2019) Vol. 108, Iss. 10, pp. 3169-3175
Closed Access | Times Cited: 17
Regulating Advanced Therapy Medicinal Products through the Hospital Exemption: An Analysis of Regulatory Approaches in Nine EU Countries
D. Coppens, Helga Gardarsdóttir, Marie L. De Bruin, et al.
Regenerative Medicine (2020) Vol. 15, Iss. 8, pp. 2015-2028
Open Access | Times Cited: 13
Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research
Fermín Sánchez‐Guijo, Damián Garcı́a-Olmo, Felipe Prósper, et al.
Cytotherapy (2019) Vol. 22, Iss. 1, pp. 1-5
Open Access | Times Cited: 8
Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side
Laura García-Pérez, Anita Ordas, Kirsten Canté-Barrett, et al.
Pharmaceutics (2020) Vol. 12, Iss. 6, pp. 549-549
Open Access | Times Cited: 7
Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?
Stefanie Klaver-Flores, Hidde A. Zittersteijn, Kirsten Canté-Barrett, et al.
Frontiers in Genome Editing (2021) Vol. 2
Open Access | Times Cited: 7
19th Annual Meeting of the Safety Pharmacology Society: regulatory and safety perspectives for advanced therapy medicinal products (cellular and gene therapy products)
Icilio Cavero, Diane Seimetz, David Koziel, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 5, pp. 553-558
Closed Access | Times Cited: 5
Beschleunigte Zulassung von Arzneimitteln: Herausforderungen für Patient:innen, Datenqualität und faire Preise
Antje Haas, Patrick May, Anja Tebinka-Olbrich, et al.
Springer eBooks (2021), pp. 105-124
Closed Access | Times Cited: 5
Is regulatory innovation fit for purpose? A case study of adaptive regulation for advanced biotherapeutics
Giovanni De Grandis, Irina Brass, Suzanne S. Farid
Regulation & Governance (2022) Vol. 17, Iss. 3, pp. 810-832
Open Access | Times Cited: 3
Scaling of cell and gene therapies to population
Sebastian Knöbel, Andreas Bosio
Handbook of clinical neurology (2024), pp. 145-154
Closed Access
Regulatory and clinical translation
Carlos Vilela, João Lucas, Patrícia Cunha, et al.
Elsevier eBooks (2024), pp. 441-462
Closed Access
Context-aware modeling for knowledge-intensive medicinal product development processes
Zeynep Ozturk Yurt, Rik Eshuis, Anna Wilbik, et al.
Software & Systems Modeling (2022) Vol. 22, Iss. 2, pp. 709-731
Open Access | Times Cited: 2
Mini Cleanroom for the Manufacture of Advanced Therapy Medicinal Products (ATMP): Bioengineered Corneal Epithelium
S Berisa, Natalia Vázquez, Manuel Chacón, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1282-1282
Open Access | Times Cited: 2
Assistance for East Waringin SMEs Go Digital
Rita Kusumawati
Jurnal Pengabdian dan Pemberdayaan Masyarakat Indonesia (2021) Vol. 1, Iss. 3, pp. 107-115
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top